Cargando…
Imidazoles and benzimidazoles as putative inhibitors of SARS-CoV-2 B.1.1.7 (Alpha) and P.1 (Gamma) variant spike glycoproteins: A computational approach
COVID-19 is an unprecedented pandemic threatening global health, and variants were discovered rapidly after the pandemic. The two variants, namely the SARS-CoV-2 B.1.1.7 (Alpha) and P.1 (Gamma), were formed by the mutations in the receptor binding domain of spike glycoprotein (SGP). These two varian...
Autores principales: | Yele, Vidyasrilekha., Sanapalli, Bharat Kumar Reddy., Mohammed, Afzal Azam. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Versita
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522534/ https://www.ncbi.nlm.nih.gov/pubmed/34690413 http://dx.doi.org/10.1007/s11696-021-01900-8 |
Ejemplares similares
-
Benzohydrazide and Phenylacetamide Scaffolds: New Putative ParE Inhibitors
por: Yele, Vidyasrilekha, et al.
Publicado: (2021) -
Ligand-based pharmacophore modeling and molecular dynamic simulation approaches to identify putative MMP-9 inhibitors
por: Sanapalli, Bharat Kumar Reddy, et al.
Publicado: (2021) -
Marine drugs as putative inhibitors against non-structural proteins of SARS-CoV-2: an in silico study
por: Patel, Simran, et al.
Publicado: (2023) -
Filamentous temperature sensitive mutant Z: a putative target to combat antibacterial resistance
por: Kifayat, Sumaiya, et al.
Publicado: (2023) -
Synthetic Imidazopyridine-Based Derivatives as Potential Inhibitors against Multi-Drug Resistant Bacterial Infections: A Review
por: Sanapalli, Bharat Kumar Reddy, et al.
Publicado: (2022)